JPUS - ETF AI Analysis
Top Page
JPMorgan Diversified Return U.S. Equity ETF (JPUS)
JPUS, the JPMorgan Diversified Return U.S. Equity ETF, has a solid overall rating driven largely by strong, high-quality holdings like Arista Networks, Apple, NetApp, and Phillips 66, which benefit from robust financial performance, positive earnings sentiment, and exposure to growth areas such as AI, cloud, and services. Some holdings like Lumentum and Philip Morris introduce caution due to valuation, leverage, and operational or technical risks, and the fund’s significant exposure to a mix of energy and technology names means investors should be aware of sector-specific volatility as a key risk factor.
JPUS vs. SPDR S&P 500 ETF (SPY)
- AUM
- 468.16M
- Region
- North America
- Expense Ratio
- 0.18%
- Beta
- 0.59
- Issuer
- JPMorgan
- Inception Date
- Sep 29, 2015
- Dividend Yield
- 2.00%
- Asset Class
- Equity
- Index Tracked
- JPMorgan Diversified Factor US Equity Index
JPUS Summary
JPUS is the JPMorgan Diversified Return U.S. Equity ETF, which follows the JPMorgan Diversified Factor US Equity Index. It invests in many large American companies across different sectors like health care, energy, utilities, and technology. Well-known names in the fund include Exxon Mobil and Philip Morris. Someone might consider JPUS for broad diversification within U.S. stocks and the potential for long-term growth, without having to pick individual companies. A key risk is that, like most stock funds, its value can go up and down with the overall U.S. stock market.
How much will it cost me?
This ETF has an expense ratio of 0.18%, which means you’ll pay about $1.80 per year for every $1,000 invested. That cost is slightly higher than the cheapest plain index ETFs but still reasonable, because this fund uses a more complex, rules-based strategy rather than simple passive indexing.
What would affect this ETF?
Because JPUS focuses on large U.S. companies across many sectors, it could benefit from a strong U.S. economy, steady or falling interest rates that support stocks, and rising demand for energy, health care, and defensive sectors where it has meaningful exposure. On the other hand, higher interest rates, slower U.S. growth, stricter energy and health care regulations, or a sharp drop in oil prices could hurt some of its top holdings in energy and related industries and weigh on overall returns.
JPUS Top 10 Holdings
JPUS is leaning on a mix of health care and energy names to do the heavy lifting, with stocks like Marathon Petroleum and Exxon Mobil rising and giving the fund a solid backbone from the energy patch. In health care, Halozyme, United Therapeutics, and Exelixis are steadily adding momentum, helped by strong earnings and promising pipelines. On the flip side, Hewlett Packard Enterprise has been more mixed lately, occasionally holding the fund back. Overall, the ETF is broadly diversified across U.S. large caps, but its recent story is powered by defensive health care and cyclical energy plays.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 APA | APA | 0.48% | $2.25M | $18.51B | 135.80% | 73Outperform |
 HPE | Hewlett Packard Enterprise | 0.45% | $2.11M | $73.13B | 125.69% | 68Neutral |
 XOM | Exxon Mobil | 0.46% | $2.16M | $769.96B | 63.27% | 74Outperform |
 HST | Host Hotels & Resorts | 0.47% | $2.18M | $17.33B | 57.34% | 77Outperform |
 NTAP | NetApp | 0.44% | $2.07M | $39.12B | 72.35% | 76Outperform |
 MPC | Marathon Petroleum | 0.44% | $2.08M | $124.89B | 127.33% | 66Neutral |
 HALO | Halozyme | 0.46% | $2.13M | $14.86B | 102.55% | 73Outperform |
 EXEL | Exelixis | 0.45% | $2.09M | $16.93B | 78.20% | 78Outperform |
 PM | Philip Morris | 0.46% | $2.14M | $325.43B | 43.24% | 61Neutral |
 COP | Conocophillips | 0.45% | $2.09M | $185.04B | 74.76% | 78Outperform |
JPUS Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JPUS, the sentiment is Positive. The current price of 142.45 is above the 20-day moving average (MA) of 140.12, above the 50-day MA of 140.25, and above the 200-day MA of 136.35, indicating a bullish trend. The MACD of 0.80 indicates Negative momentum. The RSI at 61.96 is Neutral, neither overbought nor oversold. The STOCH value of 73.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JPUS.
JPUS Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| JPUS | $142.45 | $153.00(7.41% Upside) | $468.16M | 0.18% | 71Outperform |
 INFO | $27.73 | $33.94(22.41% Upside) | $961.91M | 0.35% | 74Outperform |
 AFLG | $44.27 | $53.02(19.76% Upside) | $933.48M | 0.55% | 74Outperform |
 XVV | $57.72 | $71.09(23.16% Upside) | $902.08M | 0.08% | 74Outperform |
 PTL | $269.36 | $341.59(26.81% Upside) | $888.20M | 0.09% | 70Neutral |
 ROCY | $54.69 | $67.23(22.94% Upside) | $890.97M | 0.35% | 73Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JPUS | JPMorgan Diversified Return U.S. Equity ETF | 142.45 | 23.78 | 20.03% | |
| INFO | Harbor PanAgora Dynamic Large Cap Core ETF | 27.73 | 3.30 | 13.53% | |
| AFLG | First Trust Active Factor Large Cap ETF | 44.27 | 5.48 | 14.14% | |
| XVV | iShares ESG Screened S&P 500 ETF | 57.72 | 5.42 | 10.37% | |
| PTL | Inspire 500 ETF | 269.36 | 20.84 | 8.38% | |
| ROCY | JPMorgan Equity Premium Yield ETF | 54.69 | 6.65 | 13.83% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.